Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients

PURPOSE: Cellular immunotherapy has appeared to be a promising modality for the treatment of malignant tumor. The objective of this study was to evaluate the efficacy of cellular immunotherapy combined with minimally invasive therapy. METHODS: We searched PubMed, Web of Science and The Cochrane Libr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Min, Wang, Ying, Chi, Jiachang, Wang, Tao, Tang, Xiaoyin, Cui, Dan, Qian, Qijun, Zhai, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179243/
https://www.ncbi.nlm.nih.gov/pubmed/28006010
http://dx.doi.org/10.1371/journal.pone.0168798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179243/
https://www.ncbi.nlm.nih.gov/pubmed/28006010
http://dx.doi.org/10.1371/journal.pone.0168798

Ejemplares similares